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ABSTRACT 
Migraine is one of the most prevalent neurological disorders diagnosed throughout the 
world and can be extremely disabling, with many economic, social, physical and psychological 
health costs. Many environmental and physiological factors have been shown to precipitate 
migraine, including stress, hormonal fluctuations (in women), weather events, and changes in 
sleep and eating habits. In retrospective studies, a sizeable proportion of migraineurs also 
identify alcohol as a trigger for migraine attacks, but comparatively little research has explored 
the nature of alcohol consumption (frequency, quantity, type, rate, time of day) in relation to 
other aspects of migraine. Given limited and conflicting data regarding alcohol use and migraine, 
the purpose of the current study was to assess whether specific alcohol-related variables 
differentiate migraineurs from healthy controls and to determine the extent to which these 
alcohol variables are associated with migraine-related variables. College students are a 
population of interest because of their high rates of alcohol consumption and the documented 
high prevalence of migraine during the college years.  
The sample consisted of 192 college students with a mean age of 19.84 years (SD = 3.65), 
with 87 (45.3%) meeting ICHD-II criteria for episodic migraine and 6 (3.1%) for chronic 
migraine. Migraineurs did not differ significantly on assessed alcohol-related variables compared 
to controls (F (4,181) = 1.603, p = .176, partial η2 = .036). A multivariate regression analysis 
among the migraineurs only found that the primary predictor variables (frequency and quantity 
of alcohol consumption, severity of alcohol-related negative consequences, and number of binge 
episodes) in aggregate did not predict the combination of migraine variables (frequency, severity,
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and disability; F [12, 204] = 1.326, p = .206). However, a linear regression analysis controlling 
for anxiety, depression, and gender confirmed that alcohol variables significantly predicted 
headache-related disability, accounting for 10.6% of unique variance in disability (p <.05), but 
did not predict migraine severity or frequency in individual analyses. Headache self-efficacy was 
unrelated to alcohol-related variables. An argument is advanced for similarities between 
migraineurs and non-migraine controls on alcohol-related variables. Findings extend previous 
research and suggest the need for future studies exploring the role of alcohol use on migraine via 
experimental methods. 
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CHAPTER 1 
 
INTRODUCTION 
 
Diagnosis of Migraine 
 Migraine is one of the most prevalent neurological disorders diagnosed throughout the 
world. Epidemiological data indicate that 18% of women and 6% of men living in the United 
States have migraine (Fukui et al., 2008; Hu, Markson, Lipton, Stewart, & Berger, 1999; Jette, 
Patten, Williams, Becker, & Wiebe, 2008). Prevalence of migraine in the United States is 
comparable to prevalence rates throughout the world, although Europe has higher rates for both 
men (12%) and women (24%; Leonardi, Musicco, & Nappi, 1998). Migraine is 3 times more 
common in women than men and for this reason is often regarded as a women’s health issue 
(Jelinski et al., 2006; Lyngberg, Rasmussen, Jorgensen, & Jensen, 2005; Stewart, Lipton, 
Celentano, & Reed, 1992). Migraine affects individuals throughout life, reaching peak 
prevalence among individuals aged 25 to 44 (Jette et al., 2008; Lipton et al., 2002). Migraine is 
associated with numerous negative consequences including significant reduction in quality of life, 
decreased work performance, increased health care costs, and other practical liabilities (Baskin & 
Smitherman, 2009; Hu et al., 1999; Lipton, Hamelsky, Kolodner, Steiner, & Stewart, 2000; 
Pryse-Phillips et al., 1992; Von Korff, Stewart, Simon, & Lipton, 1998). The frequency of 
migraine and severity of associated negative consequences resulted in the World Health
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Organization ranking migraine as one of the top 20 causes of disability worldwide (Leonardi, 
Musicco, & Nappi, 1998).  
The International Classification of Headache Disorders (ICHD-2) classifies the most 
common headache types that are not attributable to secondary causes as primary headaches. 
Primary headaches include migraine and tension-type headache (TTH), as well as other less 
common subforms. Migraine is characterized by recurrent attacks of severe headache and 
associated symptoms of autonomic nervous system dysfunction and may occur with or without 
aura symptoms (e.g., visual, sensory, or speech symptoms that precede the onset of head pain by 
no more than 60 minutes). Migraine pain is typically unilateral, pulsating/throbbing in quality, 
moderate to severe in intensity, and aggravated by routine physical activity. The onset of 
migraine is usually gradual and typically lasts between 4 and 72 hours. Other common symptoms 
are nausea, vomiting, and sensitivity to light (i.e. photophobia) and sound (phonophobia) (Lipton, 
Scher, Silberstein, & Bigal, 2008). Migraine attacks that occur more than 15 days per month 
meet the criteria for chronic migraine, a rare complication of migraine often associated with 
overuse of acute migraine pharmacological agents (Lipton,	  Silberstein,	  &	  Dodick,	  2008).	   
Comorbidity of Migraine 
 Although migraine is conceptualized primarily as a neurological disorder, extant 
literature confirms a strong association between migraine and co-occurring (comorbid) 
psychiatric disorders such as major depressive disorder, generalized anxiety disorder, panic 
disorder, social phobia, and bipolar disorder (Baskin, Lipchik, & Smitherman, 2006; Baskin & 
Smitherman, 2009; Breslau & Davis, 1992; Breslau & Davis, 1993; Jette, et al., 2008; McIntyre 
et al., 2006; Oedegaard et al., 2006; Stewart, Breslau, & Keck, 1994; Swartz, Pratt, Armenian, 
Lee, & Eaton, 2000). Among psychiatric disorders, depressive and anxiety disorders have the 
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highest rates of comorbidity with migraine, and population studies have found migraineurs to be 
two to four times more likely to suffer from these conditions than nonmigraineurs (Breslau, 
Davis, Schultz, & Peterson, 1994; Jette, et al., 2008; Lanteri-Minet, Radat, Chautard, & Lucas, 
2005; Merikangas, Angst, & Isler, 1990; Oedegaard, et al., 2006). Among the anxiety disorders 
specifically, panic disorder and phobias are the most common comorbid disorders (Radat & 
Swendsen, 2005). More recent research has identified a link also between posttraumatic stress 
disorder and migraine (Peterlin et al., 2009). Comorbidity is most frequent among individuals 
suffering from migraine with aura (versus migraine without aura) (Antonaci et al., 2011; Baskin, 
Lipchik, & Smitherman, 2006; Breslau, 1998) and among those with chronic headache subforms 
(Heckman & Holroyd, 2006; Zwart et al., 2003).  
 Comorbidity between migraine and depression was initially thought to be a function of 
depression occurring in response to living with disabling headaches, but research now indicates 
that this relationship is bidirectional, with each disorder increasing the risk for onset of the other 
(Breslau et al., 1994; Breslau, Lipton, Stewart, Schultz, & Welch, 2003). This bidirectional 
relationship appears specific to migraine and not other forms of severe headache, potentially 
indicative of a shared etiology (Breslau et al., 2003; Schur, Noonan, Buchwald, Goldberg, & 
Afari, 2009). Findings in a twin study by Schur et al. (2009) indicate both disorders have a 
significant genetic basis and suggest future research should explore genetic vulnerability in the 
shared pathways of the two disorders. A similar bidirectional relationship has been found 
between migraine and panic disorder (Breslau et al., 2001), suggesting that a common etiology 
with migraine may occur across multiple psychiatric disorders. Although the pathophysiological 
mechanisms underlying this comorbidity are poorly understood, deficient serotinergic 
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availability, hormonal influences, and processes related to central nervous system sensitization 
have been implicated (Baskin & Smitherman, 2009).  
Role of Alcohol and Substance Use in Migraine 
 Despite growing awareness of the prevalence and impact of mood and anxiety disorders 
among migraineurs, other psychiatric symptoms remain largely unexplored by comparison. 
Specifically, few studies have examined relations between substance use and migraine, and the 
limited existing studies have produced mixed findings. An early study by Breslau, Davis, and 
Andreski (1991) indicated that migraineurs were at greater risk to develop alcohol and drug 
abuse and dependence disorders than were individuals without headache. By comparison, a study 
by Saunders, Merikangas, Low, Von Korff, and Kessler (2008) found only drug dependence to 
be associated with migraine, while the other substance use disorders were not uniquely related to 
migraine. Similarly, Breslau and Davis (1993) found illicit drug abuse and dependence to be 
significantly more common in migraineurs, however alcohol abuse and dependence were not.  
Other population-based studies have not observed higher prevalence rates of drug, 
alcohol, and substance use disorders among migraineurs versus nonmigraineurs (Jette, et al., 
2008; Merikangas, Angst, & Isler, 1990; Swartz et al., 2000). In the most recent large-scale study 
on this topic, Jette et al. examined 36,984 individuals who were administered a structured 
diagnostic interview for psychiatric disorders and self-reported whether they had been diagnosed 
with migraine by a physician. Results indicated no difference in 12-month prevalence of drug, 
alcohol, or substance dependence between migraineurs and nonmigraineurs. Differences in 
findings between the aforementioned studies may be a result of varying adherence to different 
DSM substance use disorders criteria as well as ICHD-II criteria for migraine. Earlier studies 
conducted by Breslau et al. and Merikangas et al. utilized DSM-III criteria for diagnosing 
5	  	  
substance use disorders, whereas later studies utilized DSM-IV criteria, the latter of which more 
strictly defines dependence. Furthermore, Jette et al. and Merikangas et al. did not use ICHD-II 
criteria for migraine to diagnose migraine, which may have contributed to both studies’ null 
findings regarding differences in prevalence rates between migraineurs and nonmigraineurs.  
 Additionally, the mixed findings regarding comorbid migraine and substance use 
disorders may be due in part to the debated precipitating nature of substance use, specifically 
alcohol use, on migraine. A variety of both external and internal factors can precipitate, or 
“trigger,” migraine attacks (Fukui, et al., 2008; Hauge, Kirchmann, & Olesen, 2010; Kelman, 
2007; Van den Bergh, Amery, & Waelkens, 1987). Research on migraine triggers has spanned 
decades, with the limitation that most studies have utilized retrospective recall, in which 
migraineurs are asked to indentify environmental and physiological factors they believe may 
have caused previous attacks (Aamodt, Stovner, Hagen, Brathen, & Zwart, 2006; Fukui, et al., 
2008; Hauge, Kirchmann, & Olesen, 2010; Ierusalimschy & Filho, 2002; Kelman, 2007; 
Peatfield, 1995; Peatfield, Glover, Littlewood, Sandler, & Rose, 1984; Spierings, Ranke, & 
Honkoop, 2001; Van den Bergh, Amery, & Waelkens, 1987). Kelman asked migraineurs to rate 
the frequency of triggers precipitating their migraine attacks and found that 75.9% of 
migraineurs reported experiencing migraine triggers, with 40.4% reporting that triggers 
precipitated migraine occasionally, 26.7% reporting that triggers precipitated migraine frequently, 
and 8.8% reporting that triggers precipitated migraine very frequently. The most commonly 
reported triggers were stress (79.7%), hormones in women (65.1%), not eating (57.3%), and 
weather changes (53.2%); alcohol was reported as a migraine trigger by 37.8% of the sample. 
Patients with migraine with aura reported having more triggers, including alcohol, than patients 
with migraine without aura. Van den Bergh, Amery, and Waelkens asked migraineurs 
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nondirective questions regarding their migraine history and trigger factors and found that 85% of 
migraineurs identified at least one trigger for their migraines. The most common triggers 
identified were alcoholic beverages (51.6%), stress (48.8%), and menstruation in women (48%). 
Patients who endorsed alcohol as a trigger also reported a significantly greater number of other 
triggers, in particular food-related triggers, than did those who denied alcohol as a migraine 
trigger. Despite frequent endorsement of migraine triggers, most existing studies on headache 
triggers inquires only about broad categories of stimuli (e.g., diet/food, environment/weather, 
sleep) without attempting to parse out specific individual triggers (e.g., types of food/beverage, 
particular weather conditions, aspects of sleep).  
In an attempt to isolate potential differential precipitation of migraine attacks, many 
studies have made a distinction between alcohol (all forms), clear spirits, red wine, and white 
wine (Fukui et al., 2008; Littlewood et al., 1988; Peatfield, 1995). Fukui et al. presented 200 
migraineurs with a list of common triggers and asked them to select any items they believed 
triggered their migraine. They found that all migraineurs reported at least one trigger, with the 
most common being related to diet (e.g., cheese, chocolate, coffee, aspartame, alcohol) (84.5%), 
sleep (75.5%), environmental factors (e.g., allergy, pollution, wind, rain, changes in weather, 
odors) (68.5%), and stress (65%). Alcohol and both red and white wine were included in dietary 
factors. Thirty-four percent of patients endorsed alcohol as a trigger, 19.5% endorsed red wine as 
a trigger, and 10.5% endorsed white wine as a trigger. Red wine precipitating migraine was 
significantly more common in women (22.2%) than men (7.9%). Other research relying on 
retrospective recall has found migraineurs to be sensitive to alcohol (all forms) as a trigger and 
more sensitive to red wine than white wine or clear spirits (Peatfield, 1995). Contrastingly, an 
experimental study by Littlewood et al., in which migraineurs with dietary triggers were 
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randomly assigned to receive either red wine or a disguised vodka mixture, found that 80% of 
migraineurs who ingested red wine experienced migraine shortly thereafter, compared with none 
who received the vodka mixture. Although the differences in results of these studies may be 
partly attributable to differences in research methodology, these discrepancies may indicate that 
behavioral differences in consumption underlie the effects of alcohol and wine as migraine 
triggers. For instance, the results of Littlewood et al. suggest that red wine has a greater 
precipitating effect than alcohol when consumed at the same frequency and quantity. Whether 
real-world drinking behaviors among migraineurs reflect these patterns remains unexplored 
empirically.  
Even though the majority of studies indicate similar findings regarding the general 
presence and nature of alcohol-related triggers, reported prevalence rates of alcohol as a trigger 
range from 6.1% to 51.5%. These wide differences in trigger endorsement may be influenced by 
medical advice to avoid known triggers (among clinic patients vs. non-treatment seeking 
samples), differences in regional attitudes towards alcohol, and the retrospective nature of most 
prior studies (Hauge, Kirchmann, & Olesen, 2010; Karli, Zarifoglu, Calisir, & Akgoz, 2005; 
Kelman, 2007; Mannix, Frame, & Solomon, 1997; Nicoletti et al., 2008; Panconesi, 2008; 
Peatfield, 1995; Spierings, Ranke, & Honkoop, 2001; Van den Bergh, Amery, & Waelkens, 
1987). In view of limited knowledge concerning the physiological mechanisms involved in 
precipitation of migraine, research has begun to focus on genetic vulnerability and neural 
activation in the presence of triggers. One potential link between alcohol and migraine is the 
presence (or lack thereof) of the alcohol dehydrogenase-2 genotype (ADH2), an enzyme integral 
to the metabolism of ethanol (García-Martín et al., 2010). Ethanol itself can potentiate 
neurogenic inflammatory responses (e.g., arterial vasodilation) that release sensory 
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neuropeptides from trigeminal neurons, and the trigeminovascular system is widely 
acknowledged to be the central source of migraine pain (Nicoletti et al., 2008). García-Martín 
and colleagues found a significantly lower prevalence of the ADH2 genotype among patients 
with migraine than healthy controls, suggesting the absence of this genotype may be associated 
with increased risk of migraine attacks after alcohol consumption. Continuing research on 
alcohol as a trigger factor may shed light on the underlying mechanisms involved in migraine 
attacks, as well as have implications for how to better manage the disorder (Fukui et al., 2008; 
Panconesi, Bartolozzi, & Guidi, 2011).  
Alcohol Use in Migraineurs 
Despite the numerous aforementioned studies indicating a precipitating relationship 
between alcohol consumption and migraine, little research has been conducted examining 
relations between specific factors associated with alcohol consumption (e.g., frequency, quantity, 
type) and clinically-relevant migraine variables beyond a diagnosis (e.g., frequency, intensity, 
migraine-related disability). Most prior studies exploring the nature of alcohol use among 
migraineurs have utilized retrospective recall, included large population-based samples not at 
specific risk of alcohol abuse, and assessed quantity and frequency of consumption only 
(Aamodt et al., 2006; Molarius, Tegelberg, & Öhrvik, 2008; Yokoyama et al., 2009). For 
instance, Molarius and colleagues studied migraine in relation to heavy drinking (half a bottle of 
strong liquor or corresponding amount of wine or beer at the same occasion) and found that 
27.8% of female heavy drinkers reported having migraines, compared with 20.6% of women 
who never drank, although no association between heavy alcohol use and migraine was found for 
men. Overall, there was an inverse association between heavy alcohol use and migraine, with the 
prevalence of migraine decreasing as frequency of heavy alcohol use increased (Odds Ratio 
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[OR] = 1 for non-heavy drinkers, OR = .90 for seldom heavy drinkers, OR = .70 for at least 
monthly heavy drinkers). Similarly, Aamodt et al. found the prevalence of migraine to be 
inversely related to units of alcohol consumed over the past 2 weeks (OR = 1 for abstainers, OR 
= .80 for 1-4 units, OR = .60 for 4-14 units, OR = .50 for > 14 units). Overall, 63% of the sample 
reported alcohol consumption in the past 2 weeks, with an equal distribution between 
migraineurs and non-headache controls. Yokoyama et al. (2009) examined specific units of 
alcohol consumed per day and also found an inverse dose-response relationship for both men 
(OR of migraine = 1 for non-drinkers, OR = .76 for < 1 unit, OR = .56 for  < 2 units, OR = .55 
for < 3 units, OR = .51 for ≥ 3 units) and women (OR = 1 for non-drinkers, OR = .77 for < 1 unit, 
OR = .72 for < 2 units, OR = .39 for < 3 units, OR = .59 for ≥ 3 units). Researchers generally 
attribute this inverse relationship to migraineurs’ avoidance of alcohol, especially in large 
quantities, because of its potential to trigger an attack as described previously (Aamodt et al., 
2006; Molarius, Tegelberg, & Öhrvik, 2008; Panconesi, 2008; Panconesi, Bartolozzi, & Guidi, 
2011; Yokoyama et al., 2006).  
To better understand alcohol consumption among migraineurs within a clinical setting, 
Mannix, Frame, and Solomon (1997) reviewed 8 years of medical charts at a specialty headache 
center and found that 12% of treatment-seeking patients reported drinking more than 1 alcoholic 
beverage per week. The percentage of migraineurs who consumed alcohol was comparable to the 
percentage of general medicine patients. Although Mannix and colleagues did not assess quantity 
of consumption or type of alcohol consumed, their results indicate a lower prevalence of alcohol 
consumption among treatment-seeking migraineurs than among migraineurs in the general 
population (31%; Aamodt et al., 2006), perhaps because clinic patients have more severe 
migraine and receive instructions to avoid common triggers (Fukui et al., 2008; Panconesi, 
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Bartolozzi, & Guidi, 2011). Further research is needed to better understand relations between 
alcohol consumption and migraine among different populations, using prospective designs, and 
assessing the impact of alcohol on other migraine-related variables.  
Goals of the Present Study 
 The aims of the present study were to assess differences in alcohol consumption between 
migraineurs and non-migraineurs and to examine relations between alcohol 
consumption/consequences and specific migraine-related variables. In addition, the current study 
controlled for depression, anxiety, and gender to determine if there were any significant 
differences in drinking behaviors even after accounting for these factors. 
 To better understand the relationship between alcohol consumption and migraine in a 
non-treatment-seeking community sample, college students served as participants. They are a 
population of interest due to their high rates of alcohol consumption and binge drinking (≥ 5 
drinks in one sitting for men, ≥ 4 drinks in one sitting for women) (Hingson, 2010; Hingson, 
Heeren, Winter, & Wechsler, 2005; Pedrelli et al., 2011). The 2010 National Health Interview 
Survey found that 56% of young adults regularly consume alcohol, compared to 51% of middle-
aged adults and 38% of elderly adults (Department of Health and Human Services, 2011). Over 
the past decade, binge drinking has increased among college students, with 45.2% of students 
reporting consuming five or more drinks in an occasion during the previous 30 days (Hingson, 
2010). Approximately 70% of college students consume alcohol on at least one occasion in a 30-
day period, with 40-50% consuming enough alcohol to be considered binge drinking (Cranford, 
Eisenberg, & Serras, 2009; Dawson, Grant, Stinson, & Chou, 2004; O’Malley & Johnston, 2002). 
Despite frequently-reported negative consequences related to alcohol consumption among this 
population (Hingson, Zha, & Weitzman, 2009), college students tend to report higher levels of 
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positive consequences (e.g., feeling relaxed, more romantic, more creative, fitting in with people) 
than negative consequences (e.g., hangover, missing classes, unplanned sex, trouble with police) 
related to alcohol use, which likely contribute to their increased relative consumption (Park & 
Grant, 2005; Slutske, 2005). College students’ positive perceptions of consequences may be due 
to the college culture downplaying the seriousness of negative consequences (Slutske, 2005). 
Further, research on alcohol and headache among this population is scarce, despite their use as 
research participants in other studies of headache and their high frequency of both alcohol 
consumption and migraine. Migraine prevalence significantly increases beginning in young 
adulthood (Lipton, Bigal, Hamelsky, & Scher, 2008), and existing studies suggest that 
approximately 25% of college students suffer from migraine (Bigal, Bigal, Betti, Bordini, & 
Speciali, 2001; Smitherman, McDermott, & Buchanan, 2011). 
An ancillary goal of the present study was to assess associations between alcohol 
consumption and headache self-efficacy among migraineurs. Headache self-efficacy refers to the 
confidence a person has that he or she can take action to prevent the onset of headache episodes 
and/or manage headache-related pain and disability (French et al., 2000). Such actions may 
include avoiding known headache triggers or limiting exposure to such triggers. Recurrent 
headache sufferers with higher headache self-efficacy exhibit fewer passive coping strategies 
than their lower self-efficacy counterparts, even after controlling for differences on headache 
severity, frequency, and chronicity (Martin, Holroyd, & Rokicki, 1993). However, self-efficacy 
differences between migraineurs as a function of alcohol consumption remain unexplored, 
despite the fact that individuals with higher headache self-efficacy would be assumed to 
consume alcohol less frequently than migraineurs with low self-efficacy, presumably because 
high self-efficacy is associated with avoidance of known triggers.  
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In summary, the current study explored relations between alcohol consumption/negative 
consequences and migraine-related variables (frequency, severity, disability, and self-efficacy).  
Hypotheses 
The following goals and hypotheses were proposed:  
Study Goal 1: To examine differences in drinking behaviors and alcohol-related variables 
between migraineurs and non-headache controls. 
Hypothesis 1a: Migraineurs would exhibit specific drinking behaviors that differentiated 
them from controls, specifically: lower frequency of consumption, lower severity of 
negative consequences related to alcohol consumption, smaller quantity of consumption, 
and a lower number of binge episodes.  
Hypothesis 1b: These differences in drinking behaviors would remain even after 
controlling for comorbid anxiety, depression, and gender.  
Study Goal 2: To determine if alcohol-related variables are predictive of migraine-related 
variables. 
Hypothesis 2a: Higher frequency of alcohol consumption, greater severity of negative 
consequences related to alcohol consumption, larger quantity of consumption, and higher 
number of binge episodes would be significant predictors of increased migraine 
frequency, severity, and disability.  
Hypothesis 2b: High headache self-efficacy would be associated with reduced frequency 
and quantity of alcohol consumption, number of binge episodes, and severity of negative 
consequences. 
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Ancillary Study Goal 3: To determine if prospective self-monitoring indicates a precipitating 
relationship between alcohol and headache. (This was included as an ancillary study goal for 
analysis in a related project.)  
Hypothesis 3: Alcohol consumption as reported prospectively on self-monitoring forms 
would be a significant trigger of next-day headache.  
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CHAPTER 2 
 
METHODS 
 
Participants 
 Participants were undergraduate students at a southeastern university who received 
modest course credit for their participation. Participants included individuals who suffered from 
migraine headaches and healthy controls who did not suffer from any type of primary headache 
other than episodic tension-type headache (ETTH). Those who met criteria for migraine as 
defined by the International Classification of Headache Disorders, Second Edition (ICHD-II; 
International Headache Society, 2004) were assigned to the migraine group. For reasons related 
to the ancillary study goal, we attempted to recruit individuals for the migraine group who 
reported four or more headaches days per month. However, we retained the 16 migraineurs 
(18.2%) who reported one to three headache days per month on the structured diagnostic 
interview.  Individuals who did not endorse any primary headaches other than episodic tension-
type headache (ETTH) were assigned to the control group. Assuming a moderate effect size (f2 = 
0.15), a power level of 0.80, and an alpha level of 0.05, a total sample size of 106 participants 
was required.  
Materials 
15	  	  
Generalized Anxiety Disorder 7-item Scale. The Generalized Anxiety Disorder 7-item 
scale (GAD-7; Spitzer, Kroenke, Williams, & Lowe, 2006) is a self-report measure of anxiety 
symptoms reflecting DSM-IV-TR (APA, 2000) diagnostic criteria for generalized anxiety 
disorder. The measure includes seven items, each with a 4-point Likert-type item response 
ranging from 0 (Not at all) to 3 (Nearly everyday). Overall scores range from 0-21 with scores 5-
9 indicating mild anxiety, scores 10-14 indicating moderate anxiety, and scores ≥ 15 indicating 
severe anxiety. The GAD-7 exhibits good reliability in terms of internal consistency (Cronbach 
α = .92) and test-retest reliability (r = .82). The GAD-7 has good convergent validity with the 
Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988) (r = .72), the Symptom 
Checklist-90 (SCL-90; Derogatis, Lipman, Rickels, Uhlenhuth, & Covi, 1974) (r = .74), and 
other measures of generalized anxiety symptoms (Spitzer, et. al, 2006). Additionally, the GAD-7 
is effective at screening for the presence of other anxiety disorders such as panic disorder, social 
phobia, and posttraumatic stress disorder (Kroenke, Spitzer, Williams, Monahan, & Lowe, 2007). 
This measure can be found in Appendix A. 
 Patient Health Questionnaire-9. The Patient Health Questionnaire-9 (PHQ-9; Kroenke, 
Spitzer, & Williams, 2001) is a self-report instrument used to screen for depression among 
medical patients, as it reflects the nine DSM-IV-TR (APA, 2000) diagnostic criteria for major 
depressive disorder. The measure consists of nine items, each with a 4-point Likert-type item 
response ranging from 0 (Not at all) to 3 (Nearly everyday). An overall score of 5 indicates mild 
depression, a score of 10 indicates moderate depression, a score of 15 indicates moderately 
severe depression, and an overall score of 20 indicates severe depression. The PHQ-9 has 
excellent internal reliability (Cronbach α = .89) and test-retest reliability (r = .84). Strong 
construct validity has been shown with the Short-Form General Health Survey (SF-20; Stewart, 
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Hays, & Ware, 1988) (r = .73), a self-report measure of sick days and symptom-related disability 
(Kroenke, Spitzer, & Williams, 2001). This measure can be found in Appendix B. 
 Migraine Disability Assessment Questionnaire. The Migraine Disability Assessment 
Questionnaire (MIDAS; Stewart, Lipton, Dowson, & Sawyer, 2001) is a 7-item self-report 
measure of headache-related disability. The first five questions ask respondents to quantify the 
number of days in the past three months that migraine has limited everyday activities (e.g., 
school/work, home life, social activities). On these five questions, total scores between 0-5 
indicate little or no disability, scores between 6-10 indicate mild disability, scores between 11-20 
indicate moderate disability, and overall scores ≥ 21 indicate severe disability. The final two 
questions on the MIDAS ask about the frequency and intensity of headaches but are not used to 
derive the total score. The MIDAS has good internal consistency (Cronbach α = .76) and test-
reliability (r = .80; Stewart, Lipton, & Sawyer, 1999). High internal consistency and test-retest 
reliability have been found in both clinical and nonclinical populations (Stewart, et al., 2001; 
Stewart, Lipton, Kolodner, Liberman, & Sawyer, 1999). The MIDAS also shows strong 
correlations with physicians’ assessments of migraine (r = .69) (Stewart et al., 2001). This 
measure can be found in Appendix C.  
 Headache Management Self-Efficacy Scale-25. The Headache Self-Efficacy Scale-25 
(HMSE-25; French, et. al, 2000) is a self-report instrument that assesses an individual’s 
confidence in his or her ability to manage headache-related pain. The measure has 25 items, each 
with a 7-point Likert-type response ranging from 1 (Strongly Disagree) to 7 (Strongly Agree). 
Nine items are reverse-scored. High total scores indicate high belief in one’s ability to manage 
headache-related pain. The HMSE-25 has excellent internal consistency (Cronbach α = .90) and 
correlates positively with the Headache-Specific Locus of Control Internal subscale (r = .40), 
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another measure of headache self-management (French, et. al, 2000). This measure can be found 
in Appendix D. 
 Daily Drinking Questionnaire. The Daily Drinking Questionnaire (DDQ; Collins, Parks, 
& Marlatt, 1985) is a self-report measure of frequency of alcohol consumption. The DDQ 
inquires about typical weekly alcohol use over the past month and heaviest weekly alcohol use 
over the past 3 months. The measure consists of two tables inquiring about the number of drinks 
and number of hours spent drinking per day over these two time periods. To assist in calculation 
of blood alcohol levels, the DDQ also asks about current height and weight of the respondent. 
The DDQ inquires also about the number of binge episodes for both men and women in the past 
month, as well as the number of binge episodes in the past month during a span of two hours or 
less. Overall scores represent the average number of drinks per week as quantified from the 
weekly use questions. Total scores ≥ 12 drinks per week indicate high-volume drinkers, 4-11 
drinks/weeks moderate-volume drinkers, 2-3 drinks/week low-volume drinkers, and <1 
drink/year abstinent or infrequent drinkers (Collins, Parks, & Marlatt, 1985). The DDQ 
correlates significantly with the Drinking Practices Questionnaire (Cahalan, Cisin, & Crossley, 
1969) (r = .50, p = .001), a longer measure used to assess volume, quantity, and frequency of 
alcohol consumption. Overall the DDQ is considered a reliable and valid measure of volume, 
quantity, and frequency of alcohol consumption (Collins, Parks, & Marlatt, 1985). This measure 
can be found in Appendix E. 
 Rutgers Alcohol Problem Index. The Rutgers Alcohol Problem Index (RAPI; White & 
Labouvie, 1989) is a self-report measure of negative alcohol-related consequences. The measure 
includes 23 items, each with a 5-point Likert-type item response (0 = never, 1 = 1-2 times, 2 = 3-
5 times, 3 = 6-10 times, 4 = more than 10 times) indicating the frequency of alcohol use or 
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alcohol-related consequences in the last 28 days. Higher scores indicate more problematic 
drinking, and total scores ≥ 8 imply clinically-significant alcohol-related problems (Neal, Corbin, 
& Fromme, 2006). The RAPI has excellent internal consistency (Cronbach α = .92) and test-
retest reliability ranging from .89 to .92 (Neal, Corbin, & Fromme, 2006; White & Labouvie, 
1989). Overall the RAPI has moderate convergent validity (White & Labouvie, 1989) and is 
comparable to the Young Adult Alcohol Consequences Questionnaire (YAACQ; Read, Kahler, 
Strong, & Colder, 2006) and Personal Experience Screen Questionnaire (PESQ; Orenstein & 
Davis, 1995), other measures assessing alcohol-related problem behaviors. The RAPI is one of 
the most commonly used measures for assessing problematic alcohol use with college-aged 
samples (Holleran & Jung, 2008; Neal, Corbin, & Fromme, 2006; Orenstein & Davis, 1995). 
This measure can be found in Appendix F. 
 Anxiety Sensitivity Index-3. The Anxiety Sensitivity Index-3 (ASI-3; Taylor, et. al, 
2007) is a self-report instrument that assesses three distinct factors of anxiety sensitivity, or the 
fear of benign arousal-related physical symptoms due to their presumed negative consequences: 
physical, cognitive, and social concerns. The measure consists of 18 items, each with a 5-point 
Likert-type item response ranging from 0 (Very little) to 4 (Very much). High scores indicate 
higher anxiety sensitivity. The ASI-3 has adequate reliability for the total score (ρ = .90), the 
Physical Concerns subscale (ρ = .84), the Cognitive Concerns subscale (ρ = .86), and the Social 
Concerns subscale (ρ = .80) (Osman, et al., 2010). Anxiety Sensitivity Index-3 items exhibit 
good internal consistency (Cronbach α= .88), and the subscales’ internal consistency ranges 
from adequate to good (Physical = .81, Cognitive = .91, Social = .79). The ASI-3 has been 
validated among both clinical and non-clinical samples, as well as among international samples 
in Canada, France, Mexico, the Netherlands, Spain, and the United States (Taylor, et. al, 2007). 
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The ASI-3 shows positive correlations with the Symptom Assessment-45 (SA-45; Osman, et al., 
2010), the Positive and Negative Affect Schedule (PANAS; Osman, et al., 2010), and the Beck 
Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988), other measures assessing 
features of anxiety and psychopathology. This measure can be found in Appendix G. 
 Demographic Questionnaire. The Demographic Questionnaire included questions 
assessing basic demographic information such as age, gender, and race/ethnic identity, as well as 
ratings of general health. This measure can be found in Appendix H. 
Structured Diagnostic Interview for Headache – Revised. The Structured Diagnostic 
Interview for Headache - Revised (SDIH-R; Andrew, Penzien, Rains, Knowlton, & McAnulty, 
1992) is a well-validated structured diagnostic interview for determining the presence of primary 
headache disorders, with modifications to comport precisely with current ICHD-II criteria (IHS, 
2004), with the exception that the minimum required migraine duration of four hours was 
reduced to two hours in light of data that younger adult migraineurs often have otherwise 
prototypical attacks lasting fewer than four hours (Rains, Penzien, Lipchik, & Ramadan, 2001). 
The SDIH-R consists of 17 items asking about various headache features as well as appendix 
questions to assess aura symptoms and cluster headache, and to rule out secondary headache 
causes such as medication overuse and post-traumatic headache. This measure can be found in 
Appendix I.  
Daily Headache Self-Monitoring Form. The Daily Headache Self-Monitoring Form 
adapted for this study (Rhudy, Penzien, & Smitherman, 2009) afforded daily recording of pain 
intensity levels, disability, stress, sleep variables, medication use, alcohol use, nicotine use, and 
menstruation among individuals with migraine. The form consists of 7 grids, one for each day of 
the week. Each grid has 5 rows corresponding to every hour of the day for recording headache, 
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headache-related disability, stress, sleep, and alcohol. Headache, disability, and stress are each 
rated on intensity scales ranging from 0 (No) to 10 (Extremely/completely). Respondents record 
ratings for these variables twice daily. For sleep and alcohol, respondents check each hour box 
that pertains to the time during which these activities occurred and also record the number of 
alcoholic beverages consumed and cigarettes smoked since their last headache, disability, and 
stress ratings (twice daily). Sleep amount and sleep quality are rated once daily. This measure 
can be found in Appendix J.  
Procedures 
Participants were recruited via campus flyers seeking individuals with migraine and 
through an online screening survey linked from the Psychology Department website. Individuals 
reporting migraine symptoms were emailed an invitation to participate in the study. Those who 
agreed to participate met individually with a clinical psychology graduate student for written 
informed consent and administration of the SDIH-R for migraine diagnostic confirmation. 
Participants without migraine or with a headache disorder other than episodic tension-type 
headache were excluded from the migraine group. Once a diagnosis of migraine was confirmed, 
participants completed the aforementioned questionnaires and subsequently self-monitored 
headache and alcohol variables for a 2-week period. They returned at the end of two weeks to 
turn in the self-monitoring forms and completed the questionnaires a second time. Individuals 
denying problem headaches or screening negative for migraine on the online screener comprised 
the control group and provided written informed consent and completed the aforementioned 
questionnaire measures in one administration (i.e., control participants did not complete daily 
self-monitoring).  
Statistical Analyses 
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 In order to test the first hypothesis, which sought to compare migraineurs and controls on 
specific drinking variables as assessed by data from the DDQ and RAPI, a MANOVA was 
conducted. A series of univariate follow-up ANOVAs of specific variables from Hypothesis 1a 
was conducted. Subsequently, a series of univariate follow-up ANCOVAS of variables from 
Hypothesis 1b were conducted to determine if observed relationships remained after controlling 
for relevant covariates. In addition to comparing migraineurs and healthy controls on specific 
drinking variables, the current study sought to “predict” migraine frequency, severity, and 
headache-related disability using alcohol-related variables. Multivariate regression analyses were 
conducted to determine the amount of variance in headache frequency (from SDIH-R), severity 
(from SDIH-R), and disability (MIDAS) predicted by frequency and quantity of alcohol 
consumption, severity of negative consequences related to alcohol consumption, and number of 
binge episodes. Subsequent linear regressions, individualized by criterion variable, were then 
conducted in order to determine the amount of variance predicted by drinking variables from 
Hypothesis 2a. 	  Additional linear regression analyses were conducted to determine the amount of 
variance in frequency and quantity of alcohol consumption, severity of negative consequences 
related to alcohol consumption, and number of binge episodes predicted by headache self-
efficacy.  
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  CHAPTER	  3	  	  RESULTS	  	  
Participant Demographics and Migraine Prevalence 
 Three hundred and twenty participants were candidates for the study based on their 
response to the flyers or survey responses. Subsequently, 128 were excluded for lack of headache 
data (20), suspect effort on the screening survey (22), other identified headache diagnoses that 
could function as confounds (probable TTH = 35, cluster headache = 3, chronic TTH = 2, 
medication overuse headache = 1, probable migraine = 4, posttraumatic headache = 4, and 
control participants with identified migraine = 28). Fourteen participants screened positive for 
migraine but did not meet criteria upon interview and thus were excluded from the study. After 
deleting nine multivariate outliers (described below), the remaining analyzed sample consisted of 
192 young adults (72.9% female) with a mean age of 19.84 years (SD = 3.65). The majority 
(75.5%) of the sample was Caucasian, 17.7% were African American, 4.2% were Asian, 1.0% 
were Hispanic/Latino, and 1.6% were of other	  ethnicities. Regarding migraine, 93 participants 
(48.4%) met ICHD-II diagnostic criteria for migraine: 87 (93.5%) with episodic migraine and 6 
(6.5%) with chronic migraine. Eighty-seven percent of migraineurs were female, and 27 
participants (29%) reported experiencing aura. Average headache frequency for migraineurs was 
6.72 days/month (SD = 4.74). They reported an average headache-related disability score of 
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26.49 (SD = 21.49) on the MIDAS and headache self-efficacy score of 97.74 (SD =21.46) on the 
HMSE-25. The majority (71.0%) of migraineurs endorsed moderate to severe migraine-related 
disability on the MIDAS. Fifty-one percent of migraineurs obtained scores (92-115) indicative of 
moderate self-efficacy on the HMSE-25. Gender distribution significantly differed between 
migraineurs and controls, such that migraineurs were more likely to be female (87.1% vs. 59.6%, 
p < .001). As shown in Table 1, migraineurs also obtained significantly higher scores than 
controls on the GAD-7 (M = 6.40 [SD = 4.27] v. 3.86 [SD = 3.66], p = .034), but only trended 
toward significance in obtaining higher depression scores on the PHQ-9 (M = 6.42 [SD = 4.66] v. 
4.06 [SD = 4.05], p = .10). As proposed initially these variables were controlled for using 
ANCOVAS in later analyses. 
Data Analytic Assumptions 
 Histograms and descriptive statistics (i.e., skewness, kurtosis) were used to assess data 
analytic assumptions for the main total scores of interest (RAPI, DDQ, PHQ-9, GAD-7) and 
found satisfactory. Levene’s test of equality of error variances confirmed that homogeneity of 
variance was met for all main criterion variables. Migraine and control participants were then 
assessed for multivariate outliers on the main total scores of interest by group using Mahalanobis 
distance: nine multivariate outliers (5 control, 4 migraine) were found using a conservative p 
<.001 cutoff and thus were removed prior to subsequent analyses.   
Migraine and Drinking Variables 
 As shown in Table 2, migraineurs reported having an average of 6.99 (SD = 9.52) drinks 
per week (vs. 9.55 [SD = 10.12] for controls), drinking on 1.55 (SD = 1.53) days per week (vs. 
1.94 [SD = 1.54] for controls), and engaging in 2.35 (SD = 3.54) binge episodes during the past 
month (vs. 2.79 [SD = 3.64] for controls). The overall MANOVA comparing groups on specific 
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drinking-related variables was nonsignificant, F (4,181) = 1.603, p = .176, partial η2 = .036. 
Although the MANOVA was nonsignificant, an ANOVA was performed on individual items to 
aid in interpretation.  Only scores on the RAPI differed significantly between groups, F (1, 189) 
= 3.945, p = .048, partial η2 = .020. However, after controlling for covariates an ANCOVA 
revealed this relationship to be no longer significant, F (1, 188) = .014, p = .906, partial η2 
= .000, with gender accounting for a significant portion of the variance, F (1,188) = 4.002, p 
= .049, partial η2 = .045. Group differences on the number of days drinking per week 
approached significance, F (1, 186) = 3.515, p = .062, partial η2 = .019. However, an analysis of 
covariance rendered this relationship to be non-significant, F (1, 186) = 2.834, p = .096, partial 
η2 = .033, with PHQ-9 scores accounting for a significant amount of the variance, F (1,186) = 
4.587, p = .035, partial η2 = .053. No significant differences were found between groups on 
number of drinks consumed per week, F (1, 186) = 3.188, p = .076, partial η2 = .017, or number 
of binge episodes in the past month, F (1, 190) = .728, p = .395, partial η2 = .004.   
Headache-Related Variables  
 In the multivariate regression analysis among the migraineurs only, primary predictor 
variables (frequency and quantity of alcohol consumption, severity of alcohol-related negative 
consequences, and number of binge episodes) were entered simultaneously to predict headache 
frequency, severity, and disability. Using Wilks’ criteria, the overall model examining the 
combined criterion variables was not significant, F (12, 204) = 1.326, p = .206. Individual linear 
regression analyses (i.e., separate for each criterion variable) controlling for gender, anxiety, and 
depression were nevertheless run to aid in interpretation. Linear regression analysis confirmed 
that frequency and quantity of alcohol consumption, severity of alcohol-related negative 
consequences, and number of binge episodes significantly predicted headache-related disability 
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as measured by the MIDAS, together accounting for 10.6% of unique variance in disability (p 
< .05; see Table 3). Within this regression, only the number of binge episodes contributed 
significantly to headache-related disability, however (p =.007). Despite their relationship with 
headache-related disability, alcohol-related variables did not predict migraine frequency or 
intensity. Subsequent linear regression analyses were run to determine if headache-self efficacy 
was predictive of frequency and quantity of alcohol consumption, negative consequences related 
to alcohol consumption, and number of binge episodes. Results indicated headache-self efficacy 
was not a significant predictor of any of these alcohol-related variables (all R2s < 0.2%).  
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CHAPTER 4 
 
DISCUSSION 
 
 The present study sought to identify associations between alcohol-related behaviors and 
migraine frequency, intensity, disability, and self-efficacy so as to gain insight into the 
relationship between alcohol and migraine among non-treatment-seeking young adults. With the 
first study goal, we examined potential differences in alcohol-related behaviors between 
migraineurs and healthy controls. With the second study goal, we explored potential 
relationships between the alcohol-related variables and headache frequency, intensity, and 
disability. In the third study goal, we investigated whether or not headache self-efficacy was 
associated with the alcohol-related behaviors reported by migraineurs. The present study also 
took into account the contributions of gender and depression/anxiety symptomatology in relation 
to migraine and alcohol consumption. Young adults were chosen as a population of interest 
because of their high rates of migraine (Bigal et al., 2001; Lipton et al., 2008), alcohol 
consumption and binge drinking (Hingson, 2010; Hingson et al., 2005; Pedrelli et al., 2011), and 
psychiatric comorbidities (Kessler et al., 2005; Smitherman, McDermott, & Buchanan, 2011). 
Conclusions from the current study are consistent with aspects of some previous studies on 
alcohol use in migraineurs and provide new information regarding specific alcohol-related 
behaviors and migraine-related variables.  
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Alcohol Consumption 
 Overall, migraineurs did not differ from non-migraine controls in the quantity or 
frequency of alcohol consumption, the number of alcohol-related negative consequences, or the 
number of binge episodes in the past month. Our adherence to an a priori power analysis defends 
against inadequate sample size as a contributing factor to these null findings. Similarities in 
alcohol consumption between individuals with and without migraine are consistent with a 
general conclusion of the Aamodt et al. (2006) study that found equal percentages of migraineurs 
and non-headache controls reporting alcohol consumption within the past two weeks, and 
provide new findings by highlighting similarities in frequency of consumption. Despite an early 
study by Breslau and colleagues (1991) that found migraineurs to be at a greater risk for alcohol 
abuse and dependence disorders compared to non-headache individuals, our findings did not 
reflect these group differences. Rather, our findings are supported by results of several large-
population based studies that found no differences in prevalence of alcohol abuse and 
dependence between migraine and non-migraine controls (Breslau & Davis, 1993; Jette et al., 
2008; Takeshima et al., 2004). As such, the bulk of existing evidence does not appear to support 
the notion that migraineurs are at increased risk for alcohol use problems.  
The similarities between groups may be a function of the college environment. 
Consuming alcohol with peers is a common college experience reported by 70% of 
undergraduates (Cranford et al., 2009). Students with migraines may not allow their migraines to 
interfere with this aspect of their college experience and thus drink alcohol despite the fact that 
they occasion headaches. This argument is strengthened by findings from a study on drinking 
behaviors and expectations among 231 college students that observed alcohol norms were 
predictive of alcohol consumption regardless of negative expectations about physiological 
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impairment related to alcohol use (Wood, Nagoshi, & Dennis, 1992). Another possible 
explanation may be that alcohol does not trigger these (and perhaps other) migraineurs’ 
headaches and therefore does not directly affect drinking behaviors. Although approximately 
one-third of migraineurs endorse alcohol as a trigger (Kelman, 2007), studies on alcohol as a 
trigger for migraine have been conducted predominantly among treatment seeking headache 
patients. Prevalence rates of alcohol as trigger may be lower among this non-treatment-seeking 
sample, although this was not specifically queried as part of the present study.  
The fact that the number of negative consequences related to alcohol consumption did not 
significantly differ between the groups could be due to the similar, moderate quantity of alcohol 
consumption reported by both groups. Moderate levels of alcohol use have been found to be 
associated with low to moderate negative consequences related to alcohol use (Collins et al., 
1985; White & Labouvie, 1989), and overall, both groups reported low to moderate negative 
consequences. Additionally, migraineurs may have viewed the type of consequences assessed by 
the RAPI differently than controls. The consequences assessed by the RAPI pertain to 
interactions with peers, family members, and the law, as well as interference with job and school 
oriented work. Although migraineurs may have had difficulties regarding job and school 
performance, they may not have attributed these difficulties to their alcohol consumption. For 
example, migraineurs might attribute the impairments “Not able to do homework or study for a 
test” and “Missed a day (or part of a day) of school or work” to their headaches rather than 
alcohol consumption, and thus endorse this statement on the MIDAS but not the RAPI. Future 
studies are warranted to confirm this latter hypothesis. In summary, migraineurs did not differ 
from controls on any of the assessed alcohol-related variables, which confirms results of larger 
studies and provides new findings regarding specific alcohol behaviors.  
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Migraine Frequency, Intensity, and Disability 
 While the alcohol-related variables in aggregate did not predict the combination of 
migraine variables, headache-related disability was predicted by alcohol consumption and 
negative consequences. This finding indicates that consuming alcohol, especially in large 
quantities within one sitting, is associated with taking more days off from school/work, 
decreased productivity, and missing social or leisure activities due to headache. A possible 
explanation for this finding is that sleep mediates this relationship, such that consuming alcohol 
leads to poorer sleep (increased slow wave sleep and decreased REM sleep [Ebrahim, Shapiro, 
Williams, & Fenwick, 2013]), which then affects attendance and performance at work and school. 
Supporting this notion, Singleton and Wolfson (2009) found that sleep mediated the relationship 
between alcohol use and academic performance in college students. Students who consumed 
alcohol reported poorer sleep quality, greater daytime sleepiness, and more missed classes. 
Similarly, sleep disturbances have repeatedly been shown to be negatively associated with 
migraines and headache-related disability (Fukui et al, 2008; Kelman & Rains, 2005; Walters, 
2011). However, sleep was not assessed as part of the present study but is a needed area for 
future studies to address.  
The lack of a relationship between alcohol-related variables and headache frequency is 
consistent with findings from a longitudinal study of 307 migraineurs that found no relationship 
between alcohol consumption and onset of migraine attack or headache frequency (Nicolodi & 
Sicuteri, 1999). The non-significant relationship between alcohol consumption and headache 
frequency and intensity may be a function of the type of alcohol consumed. In an experimental 
study by Littlewood et al. (1988), red wine but not a vodka mixture was found to trigger 
headaches, indicating that the type of alcohol is a relevant factor. Furthermore, Trotter (1982) 
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found 47.2% of college students regularly drink beer compared to 32.4% drink liquor and 20.4% 
drink wine, indicating that many college students do not regularly consume the type of alcohol 
experimentally shown to trigger migraine. Another possible explanation could be that these 
migraineurs did not drink frequently or regularly enough to influence their headaches. This 
argument is strengthened by the results of Molarius and colleagues’ (2008) study, which found a 
higher prevalence of migraine among female heavy drinkers than moderate drinkers and non-
drinkers. Considering that our headache group consisted predominantly of female moderate 
drinkers, our results might differ if individuals who drank more frequently had been oversampled.    
Headache Self-efficacy 
 Headache self-efficacy refers to the belief that an individual can prevent or manage a 
headache episode through deliberate behaviors (French et al., 2000). Avoiding known triggers is 
one action that individuals take to prevent headache episodes from occurring and is often advice 
given in medical settings (Fukui et al., 2008; Panconesi et al., 2011). For this reason, we 
expected that headache self-efficacy would be inversely associated with frequency and quantity 
of alcohol consumption. The lack of this predicted relationship may be a result of the moderate 
levels of confidence reported by the majority of this sample. While these migraineurs perceive 
they have the ability to prevent or manage their migraines at times, perhaps their self-efficacy is 
not high enough for them to believe that altering alcohol consumption would have any beneficial 
impact on headache. Another possible explanation is that these migraineurs do not believe 
alcohol causes their headaches, and consequently do not view avoidance of alcohol as a useful 
prevention strategy. Future research is needed to better understand the potential relationship 
between headache self-efficacy and alcohol, an area that has not been thoroughly explored.  
Limitations and Future Directions  
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   While this study is strengthened by its large sample size, adherence to ICHD-II 
diagnostic criteria, consideration of comorbid psychological disorders, and assessment of 
multiple aspects of alcohol-related behaviors, limitations exist. One limitation is the reliance on 
retrospective reports of alcohol consumption using self-report questionnaires. While adherence 
to a structured diagnostic headache interview and ICHD-II diagnostic criteria are strengths, daily 
diary data on alcohol consumption and interview-based diagnoses of alcohol-use disorders would 
have further strengthened the present study, although assessing alcohol-use diagnoses was not a 
goal of this study. The aforementioned ancillary study will use self-monitoring data to extend the 
present findings and test additional hypotheses related to alcohol use and triggering of migraine 
using time-series analyses. In light of this limitation, future studies seeking to further explore the 
alcohol-migraine relationship could experimentally manipulate alcohol consumption and assess 
potential effects on subsequent migraine. Although both the DDQ and RAPI are reliable and 
valid measures of alcohol use and consequences, respectively, future studies could utilize a 
longitudinal design to more accurately assess alcohol consumption over a longer period of time. 
As noted earlier, an additional limitation was that comorbid sleep disorders were not assessed, 
despite the fact that sleep is often comorbid with and influences alcohol use/problems (Johnson 
& Breslau, 2001) and that only 11% of college students report consistent good sleep quality 
(Brown, Buboltz, & Soper, 2002; Buboltz, Brown, & Soper, 2001). Future studies should assess 
relations between alcohol use and sleep among college migraineurs but incorporate interactions 
between alcohol and sleep to predict headache occurrence and disability. A final limitation is the 
unknown generalizability of these findings to older adult migraineurs and treatment-seeking 
patients. This limitation is a function of our interest in young adult migraineurs due to their 
disproportionately higher rates of alcohol use/abuse compared to the general population 
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(O’Malley & Johnston, 2002).  However, the use of a sample known for reporting alcohol use 
was beneficial in gaining insight into the potential effects of specific drinking variables on 
migraine.  
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Table 1 
Group Differences on Psychiatric Symptomatology and Gender 
 
• p < .05 
• ** p < .01 using Chi-squared test 
 Migraineurs 
M (SD) 
Controls 
M (SD) P Value 
PHQ-9 (depression) 6.42 (4.66)	   4.06 (4.05)	   .105	  
GAD-7 (anxiety) 6.40 (4.27)	   3.86 (3.66)	    .034*	  
Gender (female vs. 
male) 
81 vs. 12	   59 vs. 40	      .000**	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Table 2 
ANCOVA Results Examining Group Differences on Drinking Variables 
 
 
 
 
Migraineurs 
M (SD)	  
 
Controls 
M (SD) F Value P value 
partial 
η2	  
Days per week drinking 1.55 (1.54)	   1.94 (1.52)	   2.834	   .096	   .033	  
Drinks per week 7.13 (9.64)	     9.37 (10.08)	   3.188	   .076	   .017	  
Binge episodes in past 
month 
2.39 (3.61)	   2.63 (3.44)	    .728	   .395	   .004	  
RAPI total score  3.78 (5.91)	   5.32 (6.65)	    .014	   .906	   .000	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Table 3 
Alcohol Variables as Predictors of Migraine Variables 
 
*p < .05  **p < .01
 
F value B P value 
Model R2 (Adjusted 
R2) Unique R2 
Overall Model 1 
(Frequency) 
1.358	   	   .236	   .113 (.030)	   .046 
RAPI 	   -.092	   .529	   	    
Frequency 	   -.870	   .246	   	    
Quantity 	    .118	   .434	   	    
Number of binges 	   -.077	   .778	   	    
      
Overall Model 2 
(Intensity) 
.921	   	   .495	   .075 (-.006)	   .043 
RAPI 	   .026	   .556	   	    
Frequency 	   .251	   .271	   	    
Quantity 	   -.076	   .096	   	    
Number of binges 	    .092	   .266	   	    
      
Overall Model 3 
(Disability) 
2.571	   	    .019*	   .187 (.115)	    .106* 
RAPI 	   -1.159	   .067	   	    
Frequency 	   -2.588	   .417	   	    
Quantity 	      .036	   .955	   	    
Number of binges 	    3.175	      .007**	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GAD-7 
 
Over the last two weeks, how often have you been bothered by the following problems: (circle 
the number that applies to you) 
 
 
 
Not at 
all 
 
Several 
days 
More 
than 
half the 
days 
Nearly 
every day 
1. Feeling nervous, anxious or on edge  0 1 2 3 
2. Not being able to stop or control worrying  0 1 2 3 
3. Worrying too much about different things 0 1 2 3 
4. Trouble relaxing  0 1 2 3 
5. Being so restless that it is hard to sit still 0 1 2 3 
6. Becoming easily annoyed or irritable  0 1 2 3 
7. Feeling afraid as if something awful might  
    happen 0 1 2 3 
If you checked off any problems, how difficult 
have these problems made it for you to do your 
work, take care of things at home, or get along 
with other people? 
Not 
difficult 
at all 
Somewhat 
difficult 
Very 
difficult 
Extremely 
Difficult 
Total (For health professionals only) =  _____ 
 
GAD-7 is from Spitzer, Kroenke, Williams, & Lowe, 2006. Copyright © 2006 Pfizer Inc. Reproduced with permission. 
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PHQ-9 
 
Over the last two weeks, how often have you been bothered by any of the following problems:  
(circle the number that applies to you) 
 
 
Not at 
all 
 
Several 
days 
More 
than half 
the days 
Nearly 
every day 
1. Little interest or pleasure in doing things  0 1 2 3 
2. Feeling down, depressed, or hopeless  0 1 2 3 
3. Trouble falling or staying asleep, or sleeping 
too much 0 1 2 3 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself—or that you are 
a failure or have let yourself or your family 
down 
0 1 2 3 
7. Trouble concentrating on things, such as 
reading the newspaper or watching television 0 1 2 3 
8. Moving or speaking so slowly that other 
people could have noticed. Or the opposite—
being so fidgety or restless that you have been 
moving around a lot more than usual 
0 1 2 3 
9. Thoughts that you would be better off dead, 
or of hurting yourself in some way 0 1 2 3 
If you checked off any problems, how difficult 
have these problems made it for you to do your 
work, take care of things at home, or get along 
with other people? 
Not 
difficult 
at all 
Somewhat 
difficult 
Very 
difficult 
Extremely 
Difficult 
Total (For health professionals only) = _____ 
 
PHQ-9 is adapted from PRIME-MD®, which is a trademark of Pfizer Inc. Copyright © 1999 Pfizer Inc. Reproduced with permission.	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MIDAS 
 
Please answer the following questions about ALL your headaches you have had over the 
last 3 months. Write in your answer for each question below. 
 
1. On how many days in the last 3 months did you miss work or school because of your 
headaches?    
 
__________ days 
2. How many days in the last 3 months was your productivity at work or school reduced 
by half or more because of your headaches?  
(Do not include days you counted in question 1 where you missed work or school.)  
 
__________ days 
3. On how many days in the last 3 months did you NOT do household work because of 
your headaches?  
 
__________ days 
4. How many days in the last 3 months was your productivity in household work reduced 
by half of more because of your headaches?  
(Do not include days you counted in question 3 where you did not do household work.)  
 
__________ days 
5. On how many days in the last 3 months did you miss family, social or leisure activities 
because of your headaches?  
 
__________ days 
6. On how many days in the last 3 months did you have any headache?  
(If a headache lasted more than 1 day, count each day)  
 
__________ days 
7. On a scale of 0 - 10, on average how painful were these headaches?  
(where 0 = no pain at all and 10 = pain as bad as it can be)  
 
__________ days 
 
Lipton et al., 2003, and Stewart et al., 1999, 2003, Reprinted with permission 	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HMSE-­25	  
Instructions: You will find below a number of statements related to headaches. Please read each 
statement carefully and indicate how much you agree or disagree with the statement by circling a 
number next to it. Use the following scale as a guide:  
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DDQ 
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RAPI 
Instructions: Indicate (by circling) if any of the following have happened to you during the last 
28 days while you were using alcohol, or because of your alcohol use. When marking your 
answers, us the following code:  
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ASI-3 
Please circle the number that best corresponds to how much you agree with each item. If any 
items concern something that you have never experienced (e.g., fainting in public), then answer 
on the basis of how you think you might feel if you had such an experience. Otherwise, answer 
all items on the basis of your own experience. Be careful to circle only one number for each item 
and please answer all items. 
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Demographic Questionnaire 
Please tell us a little bit about yourself. This information is of course completely confidential. 
 
Age:__________ 
 
Sex:__________ (male/female) 
 
Race: (check one) 
 ______ Caucasian 
 ______ Afro-American 
 ______ Latin American/Hispanic 
 ______ Asian 
 ______ Other 
 
What was your highest level of education? (check one) 
 ______ did not finish high school 
 ______ graduated high school 
 ______ some college/university 
 ______ completed university 
 ______ post-graduate degree 
 
Marital status: (check one) 
 ______ single (never married) 
 ______ married 
 ______ divorced/separated 
 ______ widowed 
 
Please rate your overall health: (check one) 
 ______ excellent 
 ______ very good 
 ______ good 
 ______ fair 
 ______ poor 
 
In the past 3 months, how many days of work have you missed because of illness or feeling 
poorly? 
 ______ days or ______ I am not currently employed 
 
In the past 3 months, how many days of school have you missed because of illness or feeling 
poorly? 
 ______ days 
 
In the past 3 months, how many days were you unable to carry on your usual function at home 
because of illness or feeling poorly? 
 ______ days 
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In the past 3 months, about how many medical visits have you made (include visits to your 
regular doctor, specialists, and Urgent Care or Emergency Room) 
 ______ visits 
 
Are you currently taking any medications for a psychiatric condition, or seeing a mental health 
practitioner? 
 ______ Yes  ______ No 
 
Are you currently being treated for any psychiatric condition by a physician or by a mental 
health practitioner? 
 ______ Yes  ______ No 
 
Please rate your current level of anxiety and depression using the following scale:  
(circle one number on EACH scale) 
 
    None       Very little       Moderate       Severe       Unbearable  
 
Feelings of Anxiety  0       1       2       3       4       5       6       7       8       9       10 
 
Feelings of Depression 0       1       2       3       4       5       6       7       8       9       10 
 
 
Has a physician ever diagnosed you with migraine headaches? 
 ______ Yes  ______ No 
 
If you have been diagnosed with migraines before, on average how many migraines headaches 
do you have each month? 
   
  _______________ migraine headaches per month 
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Structured Diagnostic Interview for Headache – Revised 
(Brief Version) 	  
Patient Name: Age:  Sex:     M         
F 
 
Patient ID: Interviewer:  Date:        /       / 	  	  
The following items are selected from the long version of the Structured Diagnostic Interview for Headache 
(SDIH). The SDIH is part of the Headache Evaluation and Diagnostic System (HEDS) which includes 
software for data entry and diagnostic decision-making. These materials are intended to facilitate diagnosis 
of selected recurrent, benign headaches according to both IHS (2004) and Ad Hoc Committee (1962) 
diagnostic criteria. Optimal use of this interview requires expertise with the diagnostic classifications and 
familiarity with the computer software and manual that accompany the interview. 	   	  
  1. Does the patient get more than one type of headache?  	   	  Yes  	    No 
 (Complete a separate brief interview form for each type of headache)       Headache   #1   #2   #3 
 
  2. Select all pain locations that apply to this type of headache: (You must check at least one) 
 
       	  frontal (A)    	    temporal (B)    	  occipital (C)    	  orbital (D)    	   	  supraorbital (E) 
 
  3. Select all that apply:  top of head (F)    	    base of neck (G)     	  nasal/facial (H) 
	  	   4. What is the intensity of pain that the patient experiences with a typical headache?   ____ (Indicate rating from 0-10) 	  	   	  	  	  	  	   0	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  8	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9	   	  	  	  	  	  	  	  	  	  	  	  	  10	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  No                                 Slightly                             Mildly                              Painful                                Very                             
Extremely	  
                 Pain                               Painful                             Painful                                                                      Painful        
Painful 	  	  	  	  	  	  5. Which of the following symptoms are a “predominant feature” of this headache type (presume that the headache is 
untreated)? 
   
  Pain Location (Select only one):  Unilateral  Not Unilateral    
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  Pain Features (Select only one):  Pulsating  Pressing/Tightening (non-pulsating)  Other  
 
  6. How often does the patient experience this type of headache pain?   ____ d w m y  
(Indicate frequency in x per day, week, month, or year) 
 
  7. How long have these headaches been occurring at this rate?   ____ months  years 
  8. What is the total number of this type of headache ever experienced:  	    1  	    2-4  	  5-9  	    >10  ____  
(Indicate total number experienced) 
 
  9. How long does this headache last if untreated or unsuccessfully treated? (If patient falls asleep and wakes up 
without headache, duration of attack is until waking up. Check unremitting if patient reports never 
experiencing headache less than 7 days in duration). (Indicate duration in minutes, hours, or days)  
 
 	  Unremitting OR 
 
____ m h d  Typical Average               ____ m h d  Typical Minimum               ____ m h d  Typical Maximum 
 
10. Has anything about this headache (except freq.) changed in the last 6 months?   	  Yes  	    No 
 If YES, explain:              
             
 
11. Is the patient’s typical headache pain aggravated by routine physical activities (i.e., walking, lifting, bending, etc.)?  	  Yes  	  No 
       
12. Do any of the following symptoms occur with this headache?  
 	  Loss of appetite/Anorexia 	  Headache worsened by conversational noise levels (phonophobia) 	  Headache worsened by normal light (photophobia) 	  Nausea (Indicate intensity) 	  Mild   	  Moderate   	  Severe                 	  Vomiting (Indicate intensity)  	  Mild   	  Moderate   	  Severe                   
   
13. Does the patient ever experience symptoms before this headache pain begins?   	  Yes   	  No 
If YES, and if any of the reported symptoms provide evidence of focal cerebral cortical, and/or brainstem                   
dysfunction, complete Appendix 1 
If NO, skip to #14 
 
14. Does this headache have severe unilateral orbital, supraorbital, and/or temporal pain, and/or does the interviewer 
suspect a cluster-type headache?  	  Yes   	  No 
 If YES, complete Appendix 2 
 If NO, skip to #15 
 
15. Does the patient use any medications to relieve headache pain?   	  Yes   	  No 
  If YES, complete #15a, #15b, #15c 
  If NO, skip to #16 
 
 15a. How long has the patient been using the medication(s) to relieve headache pain?   ____ d w m y  
(Indicate duration in days, weeks, months, or years) 
 
 15b. What is the frequency of medication use?   ____days per week    ____days per month    ____ times per day 
 
 15c. Did this headache develop or markedly worsen during medication overuse?   	  Yes   	  No 
 If YES, complete Appendix 3 
If NO, skip to #16  
 
16. Is this headache related to any head injury or trauma?   	  Yes   	  No 
 If YES, complete Appendix 4 
 If NO, skip to #17 
 
17. Is this headache suspected to be attributed to a physical or other neurological disorder?   	  Yes   	  No 
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APPENDIX 1 Migraine Aura Symptoms 
 
1. How many aura attacks has the patient experienced? ____ 
 
2. What best describes the aura symptoms? (Select all that apply) 	  At least one aura symptom develops gradually over more than 4 minutes, AND/OR 2 or more 
symptoms occur in succession over 4 minutes 	  Each aura symptom lasts longer than 4 minutes but less than 60 minutes 	  Headache begins during aura OR follows aura with a headache-free interval of less than 60 minutes 
 
3. Indicate which of the following aura symptoms are present during this type of headache: (Select all that apply) 	  
 X SYMPTOM  X SYMPTOM 	   Partial loss of sight (scotoma) 	   Uncoordinated movements (ataxia) 	   Scintillation 	   Dizziness (vertigo) 	   Blurred vision 	   Ringing in ears (tinnitus) 	   Fortification spectra (zig-zag lines) 	   Decreased hearing acuity 	   Double vision 	   Decreased level of consciousness 	   Tingling or numbness (paresthesias) 	   Aphasia or unclassifiable speech 	   Weakness (paresis) 	   Poorly articulated speech (dysarthria) 	   Other:  	   Other:  
APPENDIX 2 Cluster Headache Symptoms 
 
1. Have the headaches occurred in cluster periods?  	   	  Yes  	   	  No 
If YES, complete #1a 
If NO, skip to #2 
 
     1a. What is the total number of cluster periods experienced?   ____  
 
1b. What is the duration of cluster periods?   ____ d w m y (Indicate duration in days, weeks, months, or years) 
 
2. Are the headaches separated by remission periods?  	    Yes  	    No 
If YES, complete #2a 
If NO, skip to #3 
 
2a. What is the duration of remission periods?   ____ d w m y (Indicate duration in days, weeks, months, or years) 
 
3. Indicate which of the following symptoms are present, as well as side affected, during this type of headache: 
(Select all  
      that apply)  
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APPENDIX 
3 
Medication-Overuse Headache 
Symptoms 
 
1. Has the patient withdrawn from the overused medication?  	    Yes  	    No 
 If YES, complete #1a and #1b 
 If NO, skip to #2 
 
1a. Did headache resolve or revert to its previous pattern within 2 months after discontinuation of 
overused medication?  
 Yes  	    No 
 
1b. Has medication overuse ceased within the last 2 months, but headache has not resolved or 
reverted back to its previous pattern?  	    Yes  	  No 
 
2. Has intake of ergotamine, triptan, opioid OR combination of ergotamine, triptan, opioid, or analgesic 
occurred on 2 or more days per week, for 10 or more days per month, for greater than 3 
months (Must not have combination overuse of any single class alone)?   	  Yes	  	  	   	  No 
If YES, indicate drug(s):   	    ergotamine  	    triptan  	    opioid   	  analgesic 
_____________________    
  
3. Has the patient’s intake of analgesic occurred on 2 or more days per week, for 15 or more days 
per month, for greater than 3 months?  	    Yes  	    No  
If YES, indicate drug: _____________________  
 
4. Has the patient’s intake of combination analgesics occurred on 2 or more days per week, for 10 or 
more days per month, for greater than 3 months?     Yes  	    No 
 
                If YES, indicate drugs: 
_______________________________________________________________ 
  
5. Has the patient’s intake of medication other than ergotamine, triptan, analgesic, or opioid occurred 
on a regular basis for greater than 3 months?  	   Yes  	    No 
                If YES, indicate drug: _____________________ 
 	  	  	  	  	  	  	  
 
X SYMPTOM SIDE X SYMPTOM SIDE 	  Red eyes (conjunctival injection) R     L 	   Forehead and facial sweating R     L 	   Tearing of the eyes (lacrimation) R     L 	   Pupillary constriction (miosis) R     L 	  Nasal congestion R     L 	   Drooping eyelids (ptosis) R     L 	  Runny nose (rhinorrhoea) R     L 	   Eyelid swelling (oedema) R     L 	  Restlessness or agitation  	   Other:   
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APPENDIX 4 Post-Traumatic Headache Symptoms 
 
1. Was there a loss of consciousness associated with head trauma?  	    Yes  	    No   
 If YES, complete #1a 
 If NO, skip to #2 
 
1a. What was the duration of unconsciousness?   ____ m h d (Indicate duration in minutes, hours, or days) 
 
2. Is head injury attributed to whiplash?  	    Yes  	   	  No 
 If YES, skip #5 through #8  
       If NO, complete #3 through #8 
 
3. Did headache develop within 7 days after head trauma (or after regaining consciousness)?  	    Yes  	    No 
 
4. How long has the headache continued? (Select most representative category) 
 	  Resolves within 3 months after head trauma 
 	  Persists for greater than 3 months after head trauma 
 	  Persists but 3 months have not passed since head trauma 
 
5. Did coma develop?  	    Yes  	    No  
 If YES, indicate severity on Glasgow Coma Scale:   	  GCS <13 [moderate/severe]   	  GCS >13 [mild]       
 
6. Did post-traumatic amnesia develop and continue for longer than 48 hours?  	    Yes  	    No 
 
7. Did symptoms/signs develop diagnostic of a concussion?   	    Yes  	   	  No 
 
8. Were abnormal neuroimaging results attained suggestive of a traumatic brain lesion?  	    Yes  	  No 
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  Logotherapy,	  Committee	  Member,	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CLINCAL	  EXPERIENCE	  	  
The	  Baddour	  Center,	  Senatiobia,	  MS	  (2011	  –	  Present)	  	  Individual	  and	  group	  cognitive-­‐behavioral	  therapy	  for	  adults	  living	  in	  a	  residential	  facility	  for	  individuals	  with	  intellectual	  and	  developmental	  disabilities.	  	  
University	  of	  Mississippi	  Psychological	  Services	  Center,	  Oxford,	  MS,	  (2011	  –	  Present)	  	  Individual	  cognitive-­‐behavioral	  therapy	  for	  adult	  community	  outpatients	  with	  Axis	  I	  and	  II	  disorders.	  	  
University	  of	  Mississippi	  Clinical-­Disaster	  Research	  Collaborative,	  Oxford,	  MS,	  (2010	  –	  2011)	  Worked	  with	  the	  Mississippi	  Department	  of	  Mental	  Health	  to	  collect	  information	  regarding	  the	  services	  funded	  through	  the	  Gulf	  Oil	  Spill	  Behavioral	  Health	  Grant	  Program.	  Examined	  a	  broad	  range	  of	  issues,	  such	  as	  stress,	  anxiety,	  self-­‐efficacy,	  purpose	  in	  life,	  and	  environmental	  concern,	  in	  addition	  to	  directly	  assessing	  how	  individuals	  were	  affected	  by	  the	  Gulf	  Oil	  Spill.	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